Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers

Hum Gene Ther. 2005 Sep;16(9):1016-27. doi: 10.1089/hum.2005.16.1016.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenoviridae / genetics
  • China
  • Clinical Trials as Topic / statistics & numerical data
  • Female
  • Genetic Therapy / methods*
  • Genetic Therapy / trends
  • Genetic Vectors / adverse effects
  • Genetic Vectors / genetics
  • Genetic Vectors / therapeutic use*
  • Humans
  • Male
  • Neoplasms / genetics
  • Neoplasms / therapy*
  • Quality Control
  • Research Support as Topic / trends
  • Treatment Outcome
  • Tumor Suppressor Protein p53 / adverse effects
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / therapeutic use*

Substances

  • Tumor Suppressor Protein p53